Physician profile
Brittany Barnett
NPI 1104410604
$1,542.73
in general payments reported to CMS, 2019-2025
17 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $64.27 · 2022: $23.30 · 2023: $707 · 2024: $606 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,455.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $397.36 | 2023-2024 | Rexulti |
| Abbvie INC. | $226.76 | 2023-2025 | |
| Lilly USA, LLC | $195.55 | 2023-2025 | Amyvid, Kisunla |
| Dexcom, INC. | $146.10 | 2023 | Dexcom G7 Gss (161) |
| Radius Health, INC. | $80.20 | 2023 | Tymlos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $79.95 | 2021-2023 | Xifaxan |
| Eisai INC. | $78.88 | 2024-2025 | |
| Boston Scientific Corporation | $53.05 | 2024-2025 | Eluvia, Cds - Mct/Cem Monitoring |
| Pfizer INC. | $51.17 | 2021-2024 | |
| Amgen INC. | $49.76 | 2021-2024 | Evenity, Prolia |
| Mylan Specialty L.P. | $46.50 | 2022-2023 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.68 | 2023-2024 | Jardiance |
| Sumitomo Pharma America, INC. | $31.26 | 2023-2024 | Gemtesa |
| Glaxosmithkline, LLC. | $30.40 | 2023 | Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $17.49 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $14.81 | 2023 | Cologuard Collection Kit |
| Corium, LLC | $10.81 | 2023 | Adlarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Barnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.